Sort by
Refine Your Search
-
cutting-edge imaging techniques. We lead major initiatives, including the Wellcome-funded Discovery Research Platform for Naturalistic Neuroimaging and the Max Planck UCL Centre for Computational Psychiatry
-
• Enhanced maternity, paternity and adoption pay • Employee assistance programme: Staff Support Service • Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out
-
Social and Historical Sciences. For more information, please visit http://www.ucl.ac.uk/about UCL Mechanical Engineering UCL Mechanical Engineering has been pioneering the development of engineering
-
Service Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more. As London’s Global University, we know diversity fosters creativity and innovation, and we
-
). For a full job description please visit UCL’s online recruitment portal (https://www.ucl.ac.uk/work-at-ucl/search-ucl-jobs ) and search using vacancy reference B02-09795. To apply, please upload a current
-
Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more. We will consider applications to work on a part-time, flexible, and job share basis wherever possible
-
audience. The ability to thrive in multi- and interdisciplinary research environments is a key requirement for this role. What we offer Visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find
-
maternity, paternity and adoption pay Employee assistance programme: Staff Support Service Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more. We will
-
posts On-site nursery On-site gym Enhanced maternity, paternity and adoption pay Employee assistance programme: Staff Support Service Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and